HPLC of basic drugs using non-aqueous ionic eluents: Evaluation of a 3 μm strong cation-exchange material

Biomedical Chromatography

Volumn 24, Issue 3, 2010, Pages 318-323

  Morgan, Phillip E ^a   Manwaring, Victoria ^b   Flanagan, Robert J ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

3 micron SCX; Basic drugs; Non aqueous eluents

Indexed keywords

DRUG PRODUCTS; INORGANIC COMPOUNDS; ION EXCHANGE; MASS SPECTROMETRY; PARTICLE SIZE ANALYSIS; SILICA;

3 MICRON SCX; BASIC DRUGS; CLOZAPINE; ELUENTS; MODIFIED SILICA; NON-AQUEOUS; NON-AQUEOUS ELUENT; PARTICLES SIZES; PROPYLSULFONIC ACIDS; STRONG CATION EXCHANGES;

PARTICLE SIZE;

AMITRIPTYLINE; AMMONIA; AMMONIUM ACETATE; CATION; CLOZAPINE; DESIPRAMINE; IMIPRAMINE; NORCLOZAPINE; NORTRIPTYLINE; OLANZAPINE; PERCHLORATE; QUINIDINE; QUININE;

ARTICLE; CATION EXCHANGE; DRUG PACKAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE; MASS SPECTROMETRY; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 76149090827     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1292     Document Type: Article

References (10)

1. Cabooter D, Billen J, Terryn H, Lynen F, Sandra P and Desmet G. Kinetic plot and particle size distribution analysis to discuss the performance limits of sub-2 μm and supra-2 μm particle columns. Journal of Chromatography A 2008; 1204: 1-10.
2. Croes K, McCarthy PT and Flanagan RJ. HPLC of basic drugs and quaternary ammonium compounds on microparticulate strong cation-exchange materials using methanolic or aqueous methanol eluents containing an ionic modifier. Journal of Chromatography A 1995; 693: 289-306.
3. Desmet G, Clicq D and Gzil P. Geometry-independent plate height representation methods for the direct comparison of the kinetic performance of LC supports with a different size or morphology. Analytical Chemistry 2005; 77: 4058-4070.
4. Flanagan RJ, Storey GCA, Jane I and Bhamra RK. High-performance liquid chromatographic analysis of basic drugs on silica columns using non-aqueous ionic eluents. Journal of Chromatography 1982; 247: 15-37.
5. Flanagan RJ, Bhamra RK, Walker S, Monkman S and Holt DW. Measurement of cardioactive drugs in biological samples by HPLC. Journal of Liquid Chromatography 1988; 11: 1015-1040.
6. Flanagan RJ, Harvey EJ and Spencer EP. HPLC of basic drugs on microparticulate strong cation-exchange materials-a review. Forensic Science International 2001; 121: 97-102.
7. Law B and Appleby JRG. Re-evaluation of strong cation-exchange high-performance liquid chromatography for the analysis of basic drugs. Journal of Chromatography A 1996; 725: 335-341.
8. Law B and Hussain MA. Re-evaluation of anion-exchange HPLC for the analysis of acidic compounds. Journal of Pharmaceutical and Biomedical Analysis 2000; 22: 149-154.
9. Morgan PE, Hanna-Brown M and Flanagan RJ. Characterization of a microparticulate strong anion-exchanger. Biomedical Chromatography 2006; 20: 765-773.
10. Skogh E, Reis M, Dahl M-L, Lundmark J and Bengtsson F. Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting. Therapeutic Drug Monitoring 2002; 24: 518-526.